{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T08:12:57Z","timestamp":1780474377904,"version":"3.54.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"DOI":"10.1007\/s00270-024-03933-4","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T22:37:30Z","timestamp":1736894250000},"page":"485-492","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hepatocellular Carcinoma with Vascular Invasion Treated with Resin Yttrium-90 Transarterial Radioembolization Using Single Compartment Dosimetry"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2272-7545","authenticated-orcid":false,"given":"Muhammad Mohid","family":"Tahir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aamir","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imad","family":"Nasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana C.","family":"Dinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea M.","family":"Catana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bullock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Curry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devin","family":"Eckhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Weinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muneeb","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar","family":"Sarwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,14]]},"reference":[{"key":"3933_CR1","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","volume":"76","author":"M Reig","year":"2022","unstructured":"Reig M, Forner A, Rimola J, Ferrer-F\u00e0brega J, Burrel M, Garcia-Criado \u00c1, et al. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update. J Hepatol. 2022;76:681\u201393.","journal-title":"J Hepatol"},{"key":"3933_CR2","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S1470-2045(17)30683-6","volume":"18","author":"V Vilgrain","year":"2017","unstructured":"Vilgrain V, Pereira H, Assenat E, Guiu B, Ilonca AD, Pageaux G-P, et al. Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial. Lancet Oncol. 2017;18:1624\u201336.","journal-title":"Lancet Oncol"},{"key":"3933_CR3","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1200\/JCO.2017.76.0892","volume":"36","author":"PKH Chow","year":"2018","unstructured":"Chow PKH, Gandhi M, Tan S-B, Khin MW, Khasbazar A, Ong J, et al. SIRveNIB: selective internal radiation therapy versus sorafenib in asia-pacific patients with hepatocellular carcinoma. JCO. 2018;36:1913\u201321.","journal-title":"JCO"},{"key":"3933_CR4","doi-asserted-by":"crossref","first-page":"v282","DOI":"10.1093\/annonc\/mdz247.063","volume":"30","author":"NS Hawkins","year":"2019","unstructured":"Hawkins NS, Ross PJ, Palmer DH, Chatellier G, Pereira H, Vilgrain V. Overall survival of patients with hepatocellular carcinoma receiving sorafenib versus selective internal radiation therapy with predicted osimetry in the SARAH trial. Ann Oncol. 2019;30:v282.","journal-title":"Ann Oncol"},{"key":"3933_CR5","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.2217\/fon-2019-0658","volume":"16","author":"DH Palmer","year":"2020","unstructured":"Palmer DH, Hawkins NS, Vilgrain V, Pereira H, Chatellier G, Ross PJ. Tumor burden and liver function in HCC patient selection for selective internal radiation therapy: SARAH post-hoc study. Future Oncol. 2020;16:4315\u201325.","journal-title":"Future Oncol"},{"key":"3933_CR6","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-022-05956-w","volume":"50","author":"R Salem","year":"2022","unstructured":"Salem R, Padia SA, Lam M, Chiesa C, Haste P, Sangro B, et al. Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group. Eur J Nucl Med Mol Imaging. 2022;50:328.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3933_CR7","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1007\/s00259-020-05163-5","volume":"48","author":"H Levillain","year":"2021","unstructured":"Levillain H, Bagni O, Deroose CM, Dieudonn\u00e9 A, Gnesin S, Grosser OS, et al. International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres. Eur J Nucl Med Mol Imaging. 2021;48:1570\u201384.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3933_CR8","doi-asserted-by":"crossref","first-page":"106094","DOI":"10.1016\/j.ijsu.2021.106094","volume":"102","author":"DM Liu","year":"2022","unstructured":"Liu DM, Leung TWT, Chow PKH, Ng DCE, Lee R-C, Kim YH, et al. Clinical consensus statement: selective internal radiation therapy with yttrium 90 resin microspheres for hepatocellular carcinoma in Asia. Int J Surg. 2022;102:106094.","journal-title":"Int J Surg"},{"key":"3933_CR9","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1007\/s00330-020-07231-8","volume":"31","author":"A Sarwar","year":"2021","unstructured":"Sarwar A, Kudla A, Weinstein JL, Ali A, Malik R, Bullock A, et al. Yttrium-90 radioembolization using MIRD dosimetry with resin microspheres. Eur Radiol. 2021;31:1316\u201324.","journal-title":"Eur Radiol"},{"key":"3933_CR10","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejmp.2019.09.236","volume":"68","author":"SP Kim","year":"2019","unstructured":"Kim SP, Cohalan C, Kopek N, Enger SA. A guide to 90Y radioembolization and its dosimetry. Physica Med. 2019;68:132\u201345.","journal-title":"Physica Med"},{"key":"3933_CR11","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jvir.2021.03.535","volume":"32","author":"S Frantz","year":"2021","unstructured":"Frantz S, Matsuoka L, Vaheesan K, Petroziello M, Golzarian J, Wang E, et al. Multicenter evaluation of survival and toxicities of hepatocellular carcinoma following radioembolization: analysis of the RESiN registry. J Vasc Interv Radiol. 2021;32:845\u201352.","journal-title":"J Vasc Interv Radiol"},{"key":"3933_CR12","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/1751-2980.13030","volume":"22","author":"C Martelletti","year":"2021","unstructured":"Martelletti C, Ricotti A, Gesualdo M, Carucci P, Gaia S, Rolle E, et al. Radioembolization vs sorafenib in locally advanced hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score and Bayesian analysis. J Dig Dis. 2021;22:496\u2013502.","journal-title":"J Dig Dis"},{"key":"3933_CR13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(20)30290-9","volume":"6","author":"E Garin","year":"2021","unstructured":"Garin E, Tselikas L, Guiu B, Chalaye J, Edeline J, De Baere T, et al. Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial. Lancet Gastroenterol Hepatol. 2021;6:17\u201329.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"3933_CR14","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00270-019-02404-5","volume":"43","author":"L Cardarelli-Leite","year":"2020","unstructured":"Cardarelli-Leite L, Chung J, Klass D, Marquez V, Chou F, Ho S, et al. Ablative transarterial radioembolization improves survival in patients with HCC and portal vein tumor thrombus. Cardiovasc Intervent Radiol. 2020;43:411\u201322.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"3933_CR15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2967\/jnumed.114.145177","volume":"56","author":"E Garin","year":"2015","unstructured":"Garin E, Rolland Y, Edeline J, Icard N, Lenoir L, Laffont S, et al. Personalized dosimetry with intensification using 90Y-laded glass microsphere radioembolization induces prolonged overall survival in hepatocellular carcinoma patients with portal vein thrombosis. J Nucl Med. 2015;56:339\u201346.","journal-title":"J Nucl Med"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-024-03933-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00270-024-03933-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-024-03933-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T04:37:29Z","timestamp":1743568649000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00270-024-03933-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,14]]},"references-count":15,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["3933"],"URL":"https:\/\/doi.org\/10.1007\/s00270-024-03933-4","relation":{},"ISSN":["1432-086X"],"issn-type":[{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,14]]},"assertion":[{"value":"28 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ammar Sarwar (not directly related to the manuscript): Grant Support\u2014Sirtex Medical Inc; Consultant\u2014Sirtex Medical Inc; Consultant\u2014Boston Scientific Inc; Consultant\u2014ABK Biomedical Inc; Grant Support\u2014TriSalus LifeSciences; Grant Support\u2014ABK Biomedical Inc; Medical Advisory Board\u2014Boston Scientific Inc. Andrea Bullock (not directly related to the manuscript): Consultant\u2014Oncolytics; Conference travel\u2014Agenus; Advisory\u2014Sirtex. Other Authors: None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"IRB approval was obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Subject Research"}},{"value":"A waiver of HIPAA authorization was granted by the IRB.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}